BOSTON, MA, June 12, 2025 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL, NCPLW) (the “Company”), a digital private capital markets ecosystem, today announced the formation of its Game Advisory Board to support strategic growth initiatives and deepen engagement with the online game community. The Game Advisory Board brings together a select group of industry leaders with expertise in innovative marketing, emerging technologies, strategic partnerships, and operational scale. Appointed members include Trey ...

Group 1 - Netcapital Inc. announced the acquisition of Mixie by its portfolio company Zelgor, which focuses on Web3 gaming and decentralized community engagement [1] - Mixie offers an AI-powered no-code game engine, a media network with over 100 million monthly impressions, and an accelerator model for early-stage crypto projects [2] - Zelgor aims to leverage Mixie's technology and media reach to enhance its capabilities in both Web2 and Web3 environments [3] Group 2 - Zelgor is an interactive entertainment company known for its media franchise "Noobs," featuring a unique universe of aliens [3] - Notable investors in Zelgor include Tim Draper and Kai Huang, with team members having experience in successful games like The Sims and Bioshock Infinite [3] - Netcapital Inc. operates a scalable technology platform for private companies to raise capital online and offers private equity investment opportunities [4]

Group 1 - MAGFAST has successfully raised over $10 million through multiple offerings on the Netcapital funding portal, marking it as the second largest total amount raised under Regulation Crowdfunding (Reg CF) in the consumer packaged goods industry [1] - MAGFAST specializes in designing and marketing a range of charging products for personal electronics, including a modular system of wireless and wired chargers aimed at enhancing convenience for users [2][3] - Netcapital Inc. operates a scalable technology platform that facilitates capital raising for private companies and offers private equity investment opportunities, with its funding portal registered with the SEC and a member of FINRA [3] Group 2 - The MAGFAST offering is available for a limited time on the Netcapital platform, allowing investors to review details, risks, and disclosures [2] - The company continues to expand its product offerings with innovative charging solutions, indicating a growth strategy focused on enhancing user experience [2]

Group 1 - Netcapital Inc. announced that Avadain raised over $1.275 million within the first 24 hours of its third offering on the Netcapital funding portal [1] - Avadain is a Tennessee-based company with globally patented technology for manufacturing graphene, which can be used as an additive material in various applications across growth industries [3] - Netcapital Inc. operates a scalable technology platform that enables private companies to raise capital online and offers private equity investment opportunities [4] Group 2 - The offering from Avadain is available for a limited time on the Netcapital platform, where investors can review details, risks, and disclosures [2]

Netcapital Inc. (NASDAQ:NCPL) Q3 2025 Results Conference Call March 19, 2025 10:00 AM ET Company Participants Coreen Kraysler - Chief Financial Officer Martin Kay - Chief Executive Officer Operator Good morning, and welcome to the Netcapital Inc. Third Quarter Fiscal 2025 Conference Call. [Operator Instructions] We will open the floor for your questions and comments after the presentation. [Operator Instructions]. It's now my pleasure to turn the floor over to your host, Coreen Kraysler, CFO of Netcapital I ...

Financial Performance - Revenue decreased approximately 85% year-over-year to $152,682, compared to revenue of $1,042,793 in the third quarter of fiscal year 2024[5] - Operating loss was ($1,687,692) in the third quarter fiscal 2025, compared to ($1,205,157) for the same period in the prior year[5] - Net loss was ($3,006,537) in the third quarter fiscal 2025, compared to net loss of ($2,227,542) for the same period in the prior year[5] - Loss per share was ($1.57) in the third quarter fiscal 2025, compared to loss per share of ($13.60) for the same period in the prior year[5] Cash and Assets - As of January 31, 2025, the Company had cash and cash equivalents of $614,304[5] - Total current assets decreased to $672,819 as of January 31, 2025, from $1,042,535 as of April 30, 2024[10] Liabilities and Equity - Total liabilities increased to $4,930,412 as of January 31, 2025, compared to $3,616,698 as of April 30, 2024[10] - Stockholders' equity decreased to $34,970,265 as of January 31, 2025, from $37,940,608 as of April 30, 2024[10] Business Developments - The Company established its wholly-owned broker-dealer subsidiary, Netcapital Securities Inc., which was approved by FINRA in November 2024[2] - Algernon NeuroScience Inc. engaged Netcapital Securities for a planned Regulation A offering, indicating potential future revenue sources[2]

Core Viewpoint - Netcapital Inc. reported a significant decline in revenue for the third quarter of fiscal year 2025, with a focus on establishing its wholly-owned broker-dealer subsidiary, which is expected to provide new revenue sources in the future [2][7]. Financial Performance - Revenue decreased approximately 85% year-over-year to $152,682, compared to $1,042,793 in the third quarter of fiscal year 2024 [7]. - Operating loss was ($1,687,692) in the third quarter of fiscal 2025, compared to ($1,205,157) for the same period in fiscal 2024 [7]. - Net loss was ($3,006,537) in the third quarter of fiscal 2025, compared to a net loss of ($2,227,542) for the same period in the prior year [7]. - Loss per share was ($1.57) in the third quarter of fiscal 2025, compared to a loss per share of ($13.60) for the same period in the prior year [7]. Balance Sheet Highlights - As of January 31, 2025, the company had cash and cash equivalents of $614,304, down from $863,182 as of April 30, 2024 [9]. - Total assets were $39,900,677 as of January 31, 2025, compared to $41,557,306 as of April 30, 2024 [9]. - Total liabilities increased to $4,930,412 as of January 31, 2025, from $3,616,698 as of April 30, 2024 [9]. Operational Insights - The company is focusing on its broker-dealer subsidiary, Netcapital Securities Inc., which was approved by FINRA in November 2024, aiming to enhance revenue streams [2]. - Algernon NeuroScience Inc. has engaged Netcapital Securities for a planned Regulation A offering, indicating potential future business opportunities [2].

Revenue Performance - Revenues for the nine months ended January 31, 2025, were $465,437, a decrease of approximately 90% compared to $4,604,260 for the same period in 2024[133] - For the three months ended January 31, 2025, revenues decreased by $890,111, or approximately 85%, to $152,682 compared to $1,042,793 in the same period in 2024[144] - Funding portal revenues for the three months ended January 31, 2025, were $152,393, down from $179,588 in the same period in 2024, attributed to a decrease in new issuers launching offerings[145] - Revenues for the nine months ended January 31, 2025, decreased by approximately 90% to $465,437 from $4,604,260 in the same period of 2024[152] - Funding portal revenues decreased to $464,821, down from $1,018,150, attributed to a reduction in investments and new offerings, which dropped from 64 to 32 issuers[153] Expense Management - The company recorded a decrease in payroll expenses by $54,493, or approximately 6%, to $815,024 for the three months ended January 31, 2025, due to a reduction in the number of employees[146] - Marketing expenses decreased by $19,311, or 60%, to $12,887 for the three months ended January 31, 2025, compared to $32,198 in the same period in 2024[147] - General and administrative expenses decreased by $170,884, or approximately 16%, to $921,575 for the three months ended January 31, 2025, primarily due to lower legal fees[149] - Payroll expenses decreased by approximately 9% to $2,701,318 from $2,957,394, reflecting a reduction in the number of employees[155] - Marketing expenses decreased by 90% to $31,993 from $320,817, due to fewer marketing outlets utilized[156] - General and administrative expenses increased by 50% to $3,794,013 from $2,529,378, mainly due to professional and legal fees related to the broker-dealer subsidiary[158] Cash Flow and Financing - As of January 31, 2025, cash and cash equivalents were $614,304, with negative working capital of $3,757,593, compared to $863,182 and negative working capital of $2,074,163 as of April 30, 2024[161] - Net cash used in operating activities was $4,614,630 for the nine months ended January 31, 2025, compared to $3,565,953 in 2024[168] - Net cash provided by financing activities amounted to $4,365,752, consisting of $1,979,000 from the sale of common stock and $2,386,752 from the exercise of warrants[171] - The company raised approximately $487,000 from the exercise of existing warrants at a reduced exercise price of $1.80 per share[166] Regulatory and Compliance - Netcapital Securities Inc. received approval from FINRA to become a FINRA-member broker-dealer on November 22, 2024, which is expected to expand revenue opportunities[139] - The company regained compliance with Nasdaq's continued listing requirements as of August 19, 2024, after the bid price of its common stock closed at or above $1.00 per share for 10 consecutive business days[141] Offerings and Market Activity - The total number of offerings closed on the Netcapital funding portal decreased to 63 in fiscal 2024 from 81 in fiscal 2023, with 13 offerings terminating without raising the required minimum amount in 2024[134] - The company entered into an At The Market Offering Agreement to sell shares with an aggregate sales price of up to $2,100,000, resulting in gross proceeds of $2,099,667 from the sale of 1,122,693 shares[140] Company Classification - The Company is classified as a "smaller reporting company" and is not required to provide detailed market risk disclosures[175]

Core Insights - Netcapital Inc. has engaged its subsidiary, Netcapital Securities Inc., to provide broker-dealer and administrative services for Algernon NeuroScience's planned Regulation A offering [1][2] - Algernon NeuroScience has filed a Form 1-A with the SEC, and the offering is pending qualification [2][4] - Proceeds from the offering are intended to support Algernon's research and development initiatives [2] Company Overview - Netcapital Inc. operates a fintech platform that facilitates capital raising for private companies and offers private equity investment opportunities [6] - Netcapital Securities Inc. is a FINRA-registered broker-dealer and provides compliance and operational support for offerings [1][6] - Algernon NeuroScience is a subsidiary of Algernon Pharmaceuticals focused on advancing a psychedelic DMT program for stroke and traumatic brain injury [7]

Core Viewpoint - Netcapital Inc. has entered into definitive agreements for the immediate exercise of certain outstanding warrants, significantly reducing the exercise price, which is expected to generate approximately $487,549 in gross proceeds for the company [1][4]. Group 1: Warrants and Stock Offering - The company will exercise warrants to purchase up to 270,861 shares of common stock at a reduced exercise price of $1.80 per share, down from the original price of $10.85 per share [1]. - In exchange for the immediate exercise of the warrants, the company will issue new unregistered Series A-5 and Series A-6 warrants, allowing the purchase of up to 361,148 and 180,574 shares of common stock, respectively, both at an exercise price of $2.07 per share [3]. - The offering is expected to close around January 13, 2025, subject to customary closing conditions [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general working capital purposes [4]. Group 3: Company Overview - Netcapital Inc. is a fintech company that provides a scalable technology platform for private companies to raise capital online and offers private equity investment opportunities to investors [7]. - The company's consulting group, Netcapital Advisors, provides marketing and strategic advice while taking equity positions in select companies [7].